Cargando…

Mitochondrial complex I as a therapeutic target for Alzheimer's disease

Alzheimer's disease (AD), the most prominent form of dementia in the elderly, has no cure. Strategies focused on the reduction of amyloid beta or hyperphosphorylated Tau protein have largely failed in clinical trials. Novel therapeutic targets and strategies are urgently needed. Emerging data s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trushina, Eugenia, Trushin, Sergey, Hasan, Md Fayad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897152/ https://www.ncbi.nlm.nih.gov/pubmed/35256930 http://dx.doi.org/10.1016/j.apsb.2021.11.003

Ejemplares similares

Advances in Recapitulating Alzheimer’s Disease Phenotypes Using Human Induced Pluripotent Stem Cell-Based In Vitro Models
por: Hasan, Md Fayad, et al.
Publicado: (2022)

Partial Inhibition of Complex I Restores Mitochondrial Morphology and Mitochondria-ER Communication in Hippocampus of APP/PS1 Mice
por: Panes, Jessica, et al.
Publicado: (2023)

Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease
por: Zhang, Liang, et al.
Publicado: (2015)

Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
por: Tönnies, Eric, et al.
Publicado: (2017)

Corrigendum to “Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's disease” [EBioMedicine 2 (2015) 294–305]
por: Zhang, Liang, et al.
Publicado: (2019)

Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease
por: Zhang, Liang, et al.
Publicado: (2016)

Alzheimer's disease mechanisms in peripheral cells: Promises and challenges
por: Trushina, Eugenia
Publicado: (2019)

Application of Metabolomics in Alzheimer’s Disease
por: Wilkins, Jordan Maximillian, et al.
Publicado: (2018)

Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice
por: Stojakovic, Andrea, et al.
Publicado: (2021)

Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane
por: Zhang, Liang, et al.
Publicado: (2018)

Potential Therapeutic Role of Phytochemicals to Mitigate Mitochondrial Dysfunctions in Alzheimer’s Disease
por: Rahman, Md. Ataur, et al.
Publicado: (2020)

A shape shifting organelle: unusual mitochondrial phenotype determined with three-dimensional electron microscopy reconstruction
por: Trushina, Eugenia
Publicado: (2016)

Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
por: Khan, Fabiha Zaheen, et al.
Publicado: (2022)

Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
por: Onyango, Isaac G., et al.
Publicado: (2021)

Mitochondrial Oxidative Damage in Aging and Alzheimer's Disease: Implications for Mitochondrially Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2006)

Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
por: Hoekstra, Jake G, et al.
Publicado: (2011)

Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
por: Pires, Mariana, et al.
Publicado: (2023)

Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice
por: Stojakovic, Andrea, et al.
Publicado: (2021)

Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease
por: Tapias, Victor, et al.
Publicado: (2023)

Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's Disease
por: Trushina, Eugenia, et al.
Publicado: (2012)

Hypometabolism as a therapeutic target in Alzheimer's disease
por: Costantini, Lauren C, et al.
Publicado: (2008)

Creatine as a Therapeutic Target in Alzheimer's Disease
por: Smith, Aaron N., et al.
Publicado: (2023)

Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
por: Onyango, Isaac G.
Publicado: (2018)

Mitochondrial dysfunction and Alzheimer’s disease: prospects for therapeutic intervention
por: Lim, Ji Woong, et al.
Publicado: (2020)

Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease
por: Sousa, Tiago, et al.
Publicado: (2023)

Rho GTPases as therapeutic targets in Alzheimer’s disease
por: Aguilar, Byron J., et al.
Publicado: (2017)

Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope
por: Nabi, Showkat Ul, et al.
Publicado: (2022)

Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
por: Liu, Ping, et al.
Publicado: (2022)

The Immune System as a Therapeutic Target for Alzheimer’s Disease
por: Zieneldien, Tarek, et al.
Publicado: (2022)

NADPH oxidase as a therapeutic target in Alzheimer's disease
por: Block, Michelle L
Publicado: (2008)

Exosomes: a novel therapeutic target for Alzheimer’s disease?
por: Cai, Zhi-You, et al.
Publicado: (2018)

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
por: Trushina, Eugenia, et al.
Publicado: (2013)

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
por: Cellai, Lucrezia, et al.
Publicado: (2018)

Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer’s Disease
por: Jordan, Kate L., et al.
Publicado: (2022)

Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
por: Atlante, Anna, et al.
Publicado: (2022)

Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
por: Han, Sun-Ho, et al.
Publicado: (2014)

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020)

Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
por: Raut, Snehal, et al.
Publicado: (2023)

Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer’s disease
por: Terada, Tatsuhiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ihp5p2r1o19stbe6bj0g2ja8id